Task: Please answer the following question about the molecule with SMILES CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.O.O.O.[Cl-].
Request: Is it known if this drug is the first approved in its class, regardless of the indication or route of administration, acting on a specific target?
Result: No
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.O.O.O.[Cl-]
CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.O.O.O.[Cl-]
[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride;trihydrate
Is it known if this drug is the first approved in its class, regardless of the indication or route of administration, acting on a specific target?
No